Expanding access to cancer immunotherapy: A systematic review of low-dose PD-(L)1 inhibitor strategies

Jimenez-Labaig, Pablo; Mohamed, Failah; Tan, Nur Jihan Irwan; Sanna, Ilves; El Bairi, Khalid; Khan, Shah Zeb; Akhade, Amol; Amaral, Teresa; Trapani, Dario; Patel, Amol; Harrington, Kevin J.

dc.contributor.author	Amaral, Teresa
dc.date.accessioned	2025-09-15T08:27:29Z
dc.date.available	2025-09-15T08:27:29Z
dc.date.issued	2025
dc.identifier.issn	0959-8049
dc.identifier.uri	http://hdl.handle.net/10900/170239
dc.language.iso	en	de_DE
dc.publisher	London : Elsevier Sci Ltd	de_DE
dc.relation.uri	http://dx.doi.org/10.1016/j.ejca.2025.115564	de_DE
dc.subject.ddc	610	de_DE
dc.title	Expanding access to cancer immunotherapy: A systematic review of low-dose PD-(L)1 inhibitor strategies	de_DE
dc.type	Article	de_DE
utue.quellen.id	20250630000000_00075
utue.personen.roh	Jimenez-Labaig, Pablo
utue.personen.roh	Mohamed, Failah
utue.personen.roh	Tan, Nur Jihan Irwan
utue.personen.roh	Sanna, Ilves
utue.personen.roh	El Bairi, Khalid
utue.personen.roh	Khan, Shah Zeb
utue.personen.roh	Akhade, Amol
utue.personen.roh	Amaral, Teresa
utue.personen.roh	Trapani, Dario
utue.personen.roh	Patel, Amol
utue.personen.roh	Harrington, Kevin J.
dcterms.isPartOf.ZSTitelID	European Journal of Cancer	de_DE
dcterms.isPartOf.ZS-Issue	Article 115564	de_DE
dcterms.isPartOf.ZS-Volume	225	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE